Prognostic Significance of Preoperative Neutrophil-Lymphocyte Ratio in Vascular Surgery: Systematic Review and Meta-Analysis.


Journal

Vascular and endovascular surgery
ISSN: 1938-9116
Titre abrégé: Vasc Endovascular Surg
Pays: United States
ID NLM: 101136421

Informations de publication

Date de publication:
Nov 2020
Historique:
pubmed: 26 8 2020
medline: 28 10 2020
entrez: 26 8 2020
Statut: ppublish

Résumé

The global burden of surgical vascular disease is increasing and with it, the need for cost-effective, accessible prognostic biomarkers to aid optimization of peri-operative outcomes. The neutrophil-lymphocyte ratio (NLR) is emerging as a potential candidate biomarker for perioperative risk stratification. We therefore performed this systematic review and meta-analysis on the prognostic value of elevated preoperative NLR in vascular surgery. We searched Embase (Ovid), Medline (Ovid), and the Cochrane Library database from inception to June 2019. Screening was performed, and included all peer-reviewed original research studies reporting preoperative NLR in adult emergent and elective vascular surgical patients. Studies were assessed for bias and quality of evidence using a standardized tool. Meta-analysis was performed by general linear (mixed-effects) modelling where possible, and otherwise a narrative review was conducted. Between-study heterogeneity was estimated using the Chi-squared statistic and explored qualitatively. Fourteen studies involving 5,652 patients were included. The overall methodological quality was good. Elevated preoperative NLR was associated with increased risk of long-term mortality (HR 1.40 [95%CI: 1.13-1.74], Chi-squared 60.3%, 7 studies, 3,637 people) and short-term mortality (OR: 3.08; 95%CI: 1.91-4.95), Chi-squared 66.59%, 4 studies, 945 people). Outcome measures used by fewer studies such as graft patency and amputation free survival were assessed via narrative review. NLR is a promising, readily obtainable, prognostic biomarker for mortality outcomes following vascular surgery. Heterogeneity in patient factors, severity of vascular disease, and type of vascular surgery performed renders direct comparison of outcomes from the current literature challenging. This systematic review supports further investigation for NLR measurement in pre-vascular surgical risk stratification. In particular, the establishment of a universally accepted NLR cut-off value is of importance in real-world implementation of this biomarker.

Identifiants

pubmed: 32840176
doi: 10.1177/1538574420951315
doi:

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

697-706

Auteurs

Sarah M Jackson (SM)

Department of Anaesthesia, 90134Royal Melbourne Hospital, Parkville, Victoria, Australia.
Melbourne Medical School, University of Melbourne, Parkville, Victoria, Australia.

Luke A Perry (LA)

Department of Anaesthesia, 90134Royal Melbourne Hospital, Parkville, Victoria, Australia.

Carla Borg (C)

Department of Surgery, 22457Monash University, Clayton, Victoria, Australia.

Dhruvesh M Ramson (DM)

Department of Surgery, 22457Monash University, Clayton, Victoria, Australia.

Ryan Campbell (R)

Department of Anaesthesia, 90134Royal Melbourne Hospital, Parkville, Victoria, Australia.

Zhengyang Liu (Z)

Department of Anaesthesia, 90134Royal Melbourne Hospital, Parkville, Victoria, Australia.
Melbourne Medical School, University of Melbourne, Parkville, Victoria, Australia.

Jacqueline Nguyen (J)

Department of Anaesthesia, 90134Royal Melbourne Hospital, Parkville, Victoria, Australia.
Melbourne Medical School, University of Melbourne, Parkville, Victoria, Australia.

Ned Douglas (N)

Department of Anaesthesia, 90134Royal Melbourne Hospital, Parkville, Victoria, Australia.

Juliana Kok (J)

Department of Anaesthesia, 90134Royal Melbourne Hospital, Parkville, Victoria, Australia.

Jahan Penny-Dimri (J)

Department of Surgery, 22457Monash University, Clayton, Victoria, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH